Title: Construction of a novel signature based on immune-related lncRNA to identify high and
low risk pancreatic adenocarcinoma patients
Version: 3 Date: 27 Jul 2023
Reviewer's report:
The authors performed the revision according to the reviewers' comments properly.
Title: Construction of a novel signature based on immune-related lncRNA to identify high and
low risk pancreatic adenocarcinoma patients
Version: 3 Date: 27 Jul 2023
Reviewer's report:
The authors performed the revision according to the reviewers' comments properly.
Please review this paper.
user
Title: Construction of a novel signature based on immune-related lncRNA to identify high and
low risk pancreatic adenocarcinoma patients
Version: 3 Date: 27 Jul 2023
Reviewer's report:
The authors performed the revision according to the reviewers' comments properly.
assistant